Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2008
11/04/2008CA2274244C Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
11/04/2008CA2112998C Polyphenol oxidase genes
11/02/2008CA2630701A1 Kit and method to perform a biological test designed to evaluate minerals potential for being bioleached
10/2008
10/30/2008WO2008131445A1 Device and method for transfecting cells for therapeutic use
10/30/2008WO2008131441A1 Methods and compositions involving ltas
10/30/2008WO2008131382A2 Drop-on-demand manufacturing of diagnostic test strips
10/30/2008WO2008131376A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/30/2008WO2008131324A1 A method for determining insulin sensitivity and glucose absorption
10/30/2008WO2008131314A1 Method for employing a biosensor to detect small molecules that bind directly to immobilized targets
10/30/2008WO2008131274A2 Workpiece stabilizing device
10/30/2008WO2008131261A2 Peptide biomarkers of cardiovascular disease
10/30/2008WO2008131251A1 Wet gas measurement
10/30/2008WO2008131224A2 Diabetes-related biomarkers and methods of use thereof
10/30/2008WO2008131216A1 Hapten compounds and compositions and uses thereof
10/30/2008WO2008131094A1 Method for controlling glucose uptake and insulin sensitivity
10/30/2008WO2008131063A1 Methods of use of solid support material for binding biomolecules
10/30/2008WO2008131048A2 Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells
10/30/2008WO2008131047A2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
10/30/2008WO2008131039A2 Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
10/30/2008WO2008131035A2 Methods for diagnosing, prognosing, or theranosing a condition using rare cells
10/30/2008WO2008130926A2 Characterization of n-glycans using exoglycosidases
10/30/2008WO2008130920A1 Biosensor and methods of reagent patterning for a multiple well biosensor
10/30/2008WO2008130910A1 Detection her-2/neu protein from non-isolated circulating cancer cells and treatment
10/30/2008WO2008130887A1 Biomarkers for follicular thyroid carcinoma and methods of of use
10/30/2008WO2008130686A1 Apo b measurement system and method
10/30/2008WO2008130680A1 Analytical devices with intedrated desiccant
10/30/2008WO2008130655A1 Methods for counting cells
10/30/2008WO2008130614A2 Selective and dual-action p53/mdm2/mdm4 antagonists
10/30/2008WO2008130516A1 Epigenetic biomarkers for early detection, therapeutic effectiveness, and relapse monitoring of cancer
10/30/2008WO2008130488A1 Live-cell signals of pathogen intrusion and methods thereof
10/30/2008WO2008130463A2 Multiplexed nanoscale electrochemical sensors for multi-analyte detection
10/30/2008WO2008130432A2 Nanoscale spintronic chemical sensor
10/30/2008WO2008130429A2 Detecting nitric oxide
10/30/2008WO2008130416A1 Method and system for preparing a blood sample for a disease association gene transcript test
10/30/2008WO2008130327A1 Biointerfaces for biomolecule detection
10/30/2008WO2008130263A1 Monomer and composition for producing low-percentage hydrogel and/or hydrogel having a low cross linkage content, a hydrogel and a biochip based thereon
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008130034A1 Polyamino acid synthetase and gene encoding the same
10/30/2008WO2008129928A1 Biomolecule labeling reagent, and biomolecule detection system using the same
10/30/2008WO2008129896A1 Method of diagnosing asthenospermia
10/30/2008WO2008129682A1 Method of testing prevention of metallic soap adhesion
10/30/2008WO2008129419A2 Method for detecting and/or isolating mycobacteria
10/30/2008WO2008129302A1 Assav devices and methods and components for use therein
10/30/2008WO2008129296A2 Disease markers
10/30/2008WO2008129265A1 Diagnostics and therapeutics for diabetic nephropathy involving ccl18
10/30/2008WO2008128730A2 Antagonists of bitter taste receptors and uses thereof
10/30/2008WO2008128679A1 Polypeptide as standard for proteome analysis
10/30/2008WO2008128559A1 Method for providing a compound capable of interfering with a distorted chondrocyte phenotype
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008128399A1 Device for washing and hybridization of biochips
10/30/2008WO2008128363A1 Device and method for the capacitive analysis of a moving elongate test material
10/30/2008WO2008128352A1 Methods and compositions for signal amplification
10/30/2008WO2008128333A1 A method to distinguish antibody-mediated tissue rejection from t cell-mediated tissue rejection
10/30/2008WO2008128299A1 Therapeutic protocol for treating hemoglobinopathy
10/30/2008WO2008109659A3 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells
10/30/2008WO2008109332A3 Methods and compositions for determining the efficacy of breast cancer therapeutics
10/30/2008WO2008109030A3 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer
10/30/2008WO2008108803A9 Immune cell biosensors and methods of using same
10/30/2008WO2008104062A3 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008103327A3 Mn/ca ix and bladder cancer
10/30/2008WO2008099280A3 Regulation of expression of pi3kb protein in tumors
10/30/2008WO2008098995A9 Genes involved in mitochondrial biogenesis
10/30/2008WO2008096318A3 Identification system
10/30/2008WO2008095905A3 Pathogen binding
10/30/2008WO2008084403A3 Method and apparatus for the identification of persons based on the analysis of volatile substances of said persons in the surrounding gas
10/30/2008WO2008082710A3 A method of surface plasmon resonance (spr) technology to detect genomic aberrations in patients with multiple myeloma
10/30/2008WO2008074329A3 Modulation of activity of proneurotrophins
10/30/2008WO2008070385A3 Uses of a murine model of hiv-1 infection
10/30/2008WO2008064291A3 Intermediates and methods for forming passivated surfaces on oxide layers and articles produced thereby
10/30/2008WO2008063521A3 Gene-based clinical scoring system
10/30/2008WO2008062314A3 Circulating ve-cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins.
10/30/2008WO2008061149A3 Methods and compositions for diagnosis and prognosis of renal artery stenosis
10/30/2008WO2008060489A3 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals
10/30/2008WO2008057233A3 Models of erythropoiesis
10/30/2008WO2008054724A3 Monoclonal antibodies against osteopontin
10/30/2008WO2008041849A3 Methods and means for determining satiety on saliva
10/30/2008WO2008039772A3 Polymerase variants for dna sequencing
10/30/2008WO2008036239A3 Use of lxr agonists for the treatment of osteoarthritis
10/30/2008WO2008033435A3 Detachable test sensor container having a system for reducing coding errors
10/30/2008WO2008030986A3 Molecular diagnosis and classification of malignant melanoma
10/30/2008WO2008030548A3 Voltage-sensitive fret assay employing pyrene trisulfonic donor
10/30/2008WO2008030290A3 Novel dairy herd management methods
10/30/2008WO2008024832A3 Methods for isolating and using pituitary adenoma stem cells and pituitary adenoma cells
10/30/2008WO2008022278A3 Atypical pkc mediates wnt signaling in growth cone guidance
10/30/2008WO2008022177A3 Methods for diagnosing irritable bowel syndrome
10/30/2008WO2008022036A3 Method and apparatus for protein sequence alignment using fpga devices
10/30/2008WO2008014050A3 Assays based on light emission from analyte complexes within a cassette
10/30/2008WO2008009004A3 Reagents for the detection of protein phosphorylation in signaling pathways
10/30/2008WO2007131210A3 T-cell vaccine
10/30/2008WO2007131031A3 Diagnosis of pulmonary and/or cardiovascular disease
10/30/2008WO2007130831A3 Methods and apparatus for identifying disease status using biomarkers
10/30/2008WO2007120815A3 Methods for treating lymphocyte-associated disorders by modulation of siglec activity
10/30/2008WO2007115095A3 Systems and methods for using molecular networks in genetic linkage analysis of complex traits
10/30/2008WO2007109881A9 Biomarkers useful for diagnosing prostate cancer, and methods thereof
10/30/2008WO2007109307A3 Antibodies directed to angiopoietin-like protein 4 and uses thereof
10/30/2008WO2007100782A8 Biomarkers for amyotrophic lateral sclerosis and methods using the same
10/30/2008WO2007095186A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
10/30/2008WO2007074193A3 Method for the analysis of differential expression in colorectal cancer
10/30/2008WO2007017768A3 Novel uses for drugs targeting glutamine synthetase